申请人:ABIOGEN PHARMA S.P.A.
公开号:US10736856B2
公开(公告)日:2020-08-11
The use of xibornol as a virucidal agent is described in the prophylactic or therapeutic treatment of an infection caused by one or more viruses, said viruses comprising at least one of human Adenovirus, human Rhinovirus, human Coronavirus, and a combination thereof.
西波诺尔作为一种杀病毒剂,用于预防或治疗由一种或多种病毒引起的感染,所述病毒包括人类腺病毒、人类鼻病毒、人类冠状病毒及其组合中的至少一种。